We are very proud to announce the recipients of the Maximon Longevity Prize 2022: 1st prize, the Maximon 50k CHF award - Elsa Logarinho, Group Leader @i3S – Universidade do Porto 2nd prize, the Biolytica personalized longevity program - Fedor Galkin, Research Director at Deep Longevity and Alex Zhavoronkov, Chief Longevity Officer at Deep Longevity 3rd prize, Avea Life’s supplement subscription - Heike A. Bischoff-Ferrari, Chair of Aging Medicine and Aging Research at the University of Zurich, Director of Aging Medicine at the University Hospital and City Hospital Zurich We want to congratulate the three winners on their wonderful achievements and also we want to thank our sponsors Biolytica and Avea Life for their support in awarding the 2nd and 3rd place! #MaximonLongevityPrize #longevity #science #innovation #research #healthyaging
Maximon - The Longevity Company Builder’s Post
More Relevant Posts
-
Join us at START Global Start Summit in St. Gallen on March 21st for a panel on longevity: "Building longer lives." 💡 Marc P. Bernegger and Dr. Tobias Reichmuth, Founding Partners of Maximon, will be sharing insights alongside Aksana Labokha, CEO of Rejuveron Life Sciences AG.
To view or add a comment, sign in
-
Maximon and AYUN featured in FOCUS online. Elisabeth Roider, MD, PhD, MBA, Partner & CSO/CMO at Maximon, and Dr. med. Leonie Bode, Co-Founder & Medical Director of AYUN, shared what is important for healthy aging! 💪🍃 Check out the insightful interview now: https://bit.ly/491BSnn
To view or add a comment, sign in
-
Join us at the Turn Around Aging Conference where Maximon's Partner & CSO/CMO, Elisabeth Roider, MD, PhD, MBA, will delve into the future of longevity therapies on stage. That’s not all - our Advisor, Nina Ruge, will kickstart the event with a captivating keynote on Healthy Longevity. We're proud to be part of this conference organized by our Venture Partner, Johannes Mallinckrodt. In adition, don't miss the chance to meet Maximon's Founding Partners, Marc P. Bernegger and Joerg Rieker! See you there!
To view or add a comment, sign in
-
We are delighted to announce that Nikolay Milev, Scientific Analyst at Maximon, will be presenting at Trendtage Gesundheit Luzern on Thursday, March 7th! 🎤Nikolay will explore the topic of "Decomplexifying Multimodal Diagnostics: A Pathway Towards Personalized Health." 🌟
To view or add a comment, sign in
-
MARCUARD HERITAGE, GenTwo and Maximon are excited to announce the launch of a new investment opportunity for professional investors to get exposure to Maximon's portfolio of longevity ventures https://lnkd.in/eK3TfXrP
To view or add a comment, sign in
-
🔬🌟 Proud to be part of groundbreaking research! 🌟🔬 Our Chief Scientific and Medical Officer, Elisabeth Roider, MD, PhD, MBA , led a new study published in JAMA Network Open. The team developed a mathematical model revealing the staggering economic burden of delayed cancer diagnoses, using the Covid-19 pandemic as a real-world example. They proved that even short delays can lead to immense economical costs and years of life lost. Their findings underscore the critical need for investment in early prevention medicine. Discover more about our commitment to preventive medicine and join us in prioritizing proactive healthcare for a brighter, healthier future. https://bit.ly/3IeKZpC The Guardian The Telegraph Yahoo Heraldo de Aragón
To view or add a comment, sign in
-
Maximon welcomes Elias Eisele as our newest addition to the team! 🌟 With a bachelor's degree in business administration from the University of St. Gallen and a keen interest in health and longevity, Elias brings valuable experience from health advocacy NGOs and a digital health startup specializing in complex brain disease care. 💼🧠 Joining forces with Alessandra Caroline Wagner, Simona Eicher, and Bruno Marco-Dufort, Elias steps into the role of Junior Venture Builder, offering great prospects for growth and development. Interested in gaining hands-on experience in the 'Company Building' phase? 🌱 Our next internship opportunity, starting in August/September 2024, provides a fantastic chance to dive into the world of venture development. 💡 Apply now and become a part of our journey at Maximon! https://bit.ly/3tDRiPD
To view or add a comment, sign in
-
“Longevity could become the biggest industry of the future, since everyone is interested in having a healthy, happy and perhaps even longer life,” says Marc P. Bernegger, founding partner of Maximon, a Swiss company that supports and finances the creation of companies focused on longevity. With four companies in the industry in his portfolio, including Avea Life and Biolytica, he has just announced that he has raised the investment volume to $33 million.” Explore the comprehensive article in the Argentine newspaper „LA NACION“ to gain a deeper understanding of the pivotal role Maximon plays in advancing the pursuit of a healthier and extended lifespan. https://bit.ly/49AhxWW
Vivir 100 años con salud: qué es el “health span”, el nuevo horizonte de la longevidad
lanacion.com.ar
To view or add a comment, sign in
8,761 followers
TV Adventurer | Keynote Speaker | Podcast Host
1yAn amazing night in Gstaad. 👍🏻